Table 3 |
|||||
|
Immunoexpression of Cyclin D1 in relation to EGFR in CRC |
|||||
|
Cyclin D1 |
|||||
|
|
|||||
|
Parameters |
Total |
neg./week |
moderate |
strong |
p - value |
|
|
|||||
|
mEGFR |
0.672 |
||||
|
neg./week |
49 |
5 |
19 |
25 |
|
|
moderate |
64 |
3 |
21 |
40 |
|
|
strong |
22 |
0 |
11 |
11 |
|
|
nEGFR |
< 0.001 |
||||
|
neg./week |
9 |
6 |
3 |
0 |
|
|
moderate |
49 |
1 |
42 |
6 |
|
|
strong |
77 |
1 |
6 |
70 |
|
|
|
|||||
|
Total |
135 |
8 |
51 |
76 |
|
|
|
|||||
|
CRC, colorectal carcinoma mEGFR, membrane EGFR nEGFR, nuclear EGFR test - Spearman rank correlation coefficient |
|||||
|
Dekanić et al. Diagnostic Pathology 2011 6:108 doi:10.1186/1746-1596-6-108 |
|||||
